Zhong Ji Longevity Science Group Ltd. Enters MOU for Potential Acquisition of Asian Integrated Cell Laboratory

Reuters

08/04

Zhong Ji Longevity Science Group Ltd. Enters MOU for Potential Acquisition of Asian Integrated Cell Laboratory

Zhong Ji Longevity Science Group Limited has announced that it has entered into a non-legally binding memorandum of understanding with China International Osteoarticular Medical Group Limited. The agreement outlines a potential acquisition where Zhong Ji Longevity Science Group intends to purchase 100% of the shareholding interest in Asian Integrated Cell Laboratory Limited. This acquisition aligns with the company's strategic focus on advancing cell therapies and cell drugs in areas such as cancer prevention, anti-aging, and knee health. Mr. Yan Li, the Chairman and executive Director of Zhong Ji Longevity Science Group, is also the sole director and sole shareholder of the Vendor, making the transaction a connected transaction. The company plans to keep shareholders and investors updated with further announcements as developments occur.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhong Ji Longevity Science Group Ltd. published the original content used to generate this news brief on August 04, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2556538915"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2556538915\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2556538915?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-04 19:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2556538915","market":"fut","top_or_hot":-1,"title":"Zhong Ji Longevity Science Group Ltd. Enters MOU for Potential Acquisition of Asian Integrated Cell Laboratory","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Zhong Ji Longevity Science Group Ltd. Enters MOU for Potential Acquisition of Asian Integrated Cell Laboratory\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Zhong Ji Longevity Science Group Limited has announced that it has entered into a non-legally binding memorandum of understanding with China International Osteoarticular Medical Group Limited. The agreement outlines a potential acquisition where Zhong Ji Longevity Science Group intends to purchase 100% of the shareholding interest in Asian Integrated Cell Laboratory Limited. This acquisition aligns with the company's strategic focus on advancing cell therapies and cell drugs in areas such as cancer prevention, anti-aging, and knee health. Mr. Yan Li, the Chairman and executive Director of Zhong Ji Longevity Science Group, is also the sole director and sole shareholder of the Vendor, making the transaction a connected transaction. The company plans to keep shareholders and investors updated with further announcements as developments occur.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhong Ji Longevity Science Group Ltd. published the original content used to generate this news brief on August 04, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zhong Ji Longevity Science Group Ltd. Enters MOU for Potential Acquisition of Asian Integrated Cell Laboratory</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZhong Ji Longevity Science Group Ltd. Enters MOU for Potential Acquisition of Asian Integrated Cell Laboratory\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-04 19:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Zhong Ji Longevity Science Group Ltd. Enters MOU for Potential Acquisition of Asian Integrated Cell Laboratory\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Zhong Ji Longevity Science Group Limited has announced that it has entered into a non-legally binding memorandum of understanding with China International Osteoarticular Medical Group Limited. The agreement outlines a potential acquisition where Zhong Ji Longevity Science Group intends to purchase 100% of the shareholding interest in Asian Integrated Cell Laboratory Limited. This acquisition aligns with the company's strategic focus on advancing cell therapies and cell drugs in areas such as cancer prevention, anti-aging, and knee health. Mr. Yan Li, the Chairman and executive Director of Zhong Ji Longevity Science Group, is also the sole director and sole shareholder of the Vendor, making the transaction a connected transaction. The company plans to keep shareholders and investors updated with further announcements as developments occur.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhong Ji Longevity Science Group Ltd. published the original content used to generate this news brief on August 04, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1186","symbol_name":"特殊金融服务","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nNDLmVYXK:1","article_id":"2556538915","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2556538915","pubTimestamp":1754308736,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Zhong Ji Longevity Science Group Limited has announced that it has entered into a non-legally binding memorandum of understanding with China International Osteoarticular Medical Group Limited. The agreement outlines a potential acquisition where Zhong Ji Longevity Science Group intends to purchase 100% of the shareholding interest in Asian Integrated Cell Laboratory Limited. This acquisition aligns with the company's strategic focus on advancing cell therapies and cell drugs in areas such as cancer prevention, anti-aging, and knee health. Mr. Yan Li, the Chairman and executive Director of Zhong Ji Longevity Science Group, is also the sole director and sole shareholder of the Vendor, making the transaction a connected transaction. The company plans to keep shareholders and investors updated with further announcements as developments occur.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and t","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1186":"特殊金融服务","00767":"中基长寿科学"},"translate_title":"中基长寿科学集团有限公司就可能收购亚洲综合细胞实验室签署谅解备忘录","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00767":0.9},"content_text":"Zhong Ji Longevity Science Group Ltd. Enters MOU for Potential Acquisition of Asian Integrated Cell Laboratory\n    \n\n        Zhong Ji Longevity Science Group Limited has announced that it has entered into a non-legally binding memorandum of understanding with China International Osteoarticular Medical Group Limited. The agreement outlines a potential acquisition where Zhong Ji Longevity Science Group intends to purchase 100% of the shareholding interest in Asian Integrated Cell Laboratory Limited. This acquisition aligns with the company's strategic focus on advancing cell therapies and cell drugs in areas such as cancer prevention, anti-aging, and knee health. Mr. Yan Li, the Chairman and executive Director of Zhong Ji Longevity Science Group, is also the sole director and sole shareholder of the Vendor, making the transaction a connected transaction. The company plans to keep shareholders and investors updated with further announcements as developments occur.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhong Ji Longevity Science Group Ltd. published the original content used to generate this news brief on August 04, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}